Comparison of enzyme phenotypes in human bladder tumours and experimentally induced hyperplastic and neoplastic lesions of the rat urinary bladder. A combined histochemical and immunohistochemical approach.
The expression of a number of enzymes involved in drug metabolism, membrane function etc. was compared in hyperplastic and neoplastic lesions of the rat bladder and in human bladder tumours. Transitional cell carcinomas (TCC) in both rat and Man were characterized by decreased alkaline phosphatase (ALP) and increased gamma-glutamyl transpeptidase (GGT), beta-glucuronidase (beta-G1), succinate dehydrogenase (SD) and glucose-6-phosphate dehydrogenase (G6PD) activities. In addition, binding for antibodies specific for different cytochrome P-450 species (UT50, PB3a, MC1, MC2) and microsomal epoxide hydrolase (mEHb) was elevated in both murine and human tumours. Comparison of the enzyme phenotype in hyperplastic lesions induced by freeze ulceration or uracil administration with that in preneoplastic papillary or nodular hyperplasia (PNH) and TCC suggested, however, that most of the alteration in enzyme content or activity was non-specific and related to requirements for epithelial cell proliferation. On the other hand, the decreased ALP, and increased GGT and beta-G1 activity appeared more directly related to neoplastic transformation. The results suggested that qualitative differences exist between reactive hyperplasia and preneoplastic or neoplastic lesions in the urinary bladder. The finding of increased cytochrome P-450, in clear contrast to the reduction characteristic of preneoplastic hepatic lesions, may be important with regard to the observed difference in neoplastic transformation between the bladder and liver in response to drug metabolising enzyme inducers.
Tsuda
H
H
First Department of Pathology, Nagoya City University Medical School, Japan.
Inoue
T
T
Asamoto
M
M
Fukushima
S
S
Ito
N
N
Okamura
T
T
Ohtaguro
K
K
Washida
H
H
Satoh
K
K
Amelizad
Z
Z
D000469:Alkaline Phosphatase / Q000235:genetics / Q000378:metabolism; D000818:Animals; D002295:Carcinoma, Transitional Cell / Q000201:enzymology / Q000235:genetics*; D005954:Glucosephosphate Dehydrogenase / Q000235:genetics; D005966:Glucuronidase / Q000235:genetics; D006651:Histocytochemistry; D006801:Humans; D006965:Hyperplasia; D007150:Immunohistochemistry; D008297:Male; D010641:Phenotype; D051381:Rats; D011916:Rats, Inbred F344; D013385:Succinate Dehydrogenase / Q000235:genetics; D001743:Urinary Bladder / Q000473:pathology*; D001749:Urinary Bladder Neoplasms / Q000201:enzymology / Q000235:genetics*; D005723:gamma-Glutamyltransferase / Q000235:genetics
D005954:Glucosephosphate Dehydrogenase; D013385:Succinate Dehydrogenase; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase; D005966:Glucuronidase